KA Imaging, a 2016 CAAP Company, is one of the first three companies to receive funding via FACIT's new Prospects Oncology Fund.
The non-dilutive funding provided by FACIT - Fight Against Cancer Innovation Trust - will help KA Imaging to develop their nascent technology in Ontario. This support also aligns with FACIT's Prospects Fund as a key gateway to oncology innovation opportunities in the province. The Fund plays a critical role in helping to de-risk early stage innovations and increase favourable exposure to FACIT's larger network of commercial partners and investors.
““We’re thrilled to partner with these Ontario entrepreneurs and their oncology medical innovations through the Prospects Oncology Fund. Through access to risk capital, these exciting technologies can now accelerate their path toward commercial validation. Congratulations to all the strong applicants and in particular these awardees in their fight against cancer.””
Read the press release here.